Literature DB >> 18417524

Efficacy and safety of rituximab in a patient with active rheumatoid arthritis and chronic disseminated pulmonary aspergillosis and history of tuberculosis.

N Jung, K Owczarczyk, M Hellmann, C Lehmann, G Fätkenheuer, M Hallek, A Rubbert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18417524     DOI： 10.1093/rheumatology/ken143

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  9 in total

1.  [Recommendations for use of rituximab in patients with rheumatoid arthritis].

Authors:  A Rubbert-Roth; G R Burmester; T Dörner; A Gause
Journal:  Z Rheumatol       Date:  2014-03       Impact factor: 1.372

Review 2.  A comprehensive review of rituximab therapy in rheumatoid arthritis patients.

Authors:  Soheil Tavakolpour; Samira Alesaeidi; Mohammad Darvishi; Mojtaba GhasemiAdl; Sahar Darabi-Monadi; Meisam Akhlaghdoust; Somayeh Elikaei Behjati; Arash Jafarieh
Journal:  Clin Rheumatol       Date:  2019-08-01       Impact factor: 2.980

Review 3.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

4.  Tuberculosis Arthritis in the Wrist While Using Rituximab for Rheumatoid Arthritis Treatment.

Authors:  Hasan Ulusoy; Özge Acar Cakan; Tibel Tuna
Journal:  Open Access Rheumatol       Date:  2020-09-14

5.  Rituximab seems to be a safer alternative in patients with active rheumatoid arthritis with tuberculosis.

Authors:  Yavuz Pehlivan; Bunyamin Kisacik; Vuslat Kecik Bosnak; Ahmet Mesut Onat
Journal:  BMJ Case Rep       Date:  2013-01-21

6.  [Medicinal prophylaxis during intensified immunosuppression in children and adolescents : part 2].

Authors:  F Speth; N Wellinghausen; J-P Haas
Journal:  Z Rheumatol       Date:  2013-11       Impact factor: 1.372

7.  Sinus aspergilloma in rheumatoid arthritis before or during tumor necrosis factor-alpha antagonist therapy.

Authors:  Ariane Leboime; Jean-Marie Berthelot; Yannick Allanore; Lama Khalil-Kallouche; Philippe Herman; Philippe Orcel; Frédéric Lioté
Journal:  Arthritis Res Ther       Date:  2009-11-03       Impact factor: 5.156

8.  Choice of Biologic Therapy for Patients with Rheumatoid Arthritis: The Infection Perspective.

Authors:  Filip De Keyser
Journal:  Curr Rheumatol Rev       Date:  2011-02

9.  Risk of tuberculosis reactivation with rituximab therapy.

Authors:  Amjad Alkadi; Najla Alduaiji; Ali Alrehaily
Journal:  Int J Health Sci (Qassim)       Date:  2017 Apr-Jun
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.